BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 12614526)

  • 1. Acupuncture and bronchial asthma: a long-term randomized study of the effects of real versus sham acupuncture compared to controls in patients with bronchial asthma.
    Medici TC; Grebski E; Wu J; Hinz G; Wüthrich B
    J Altern Complement Med; 2002 Dec; 8(6):737-50; discussion 751-4. PubMed ID: 12614526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sensitivity of sputum eosinophil cationic protein level for monitoring asthmatic patients with normal peak expiratory flow].
    Nakazawa T; Kagami M; Matumura R; Kawashima T; Matuzuwa Y; Takada M
    Arerugi; 1999 Oct; 48(10):1153-60. PubMed ID: 10554401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between induced sputum cell counts and fluid-phase eosinophil cationic protein and clinical or physiologic profiles in mild asthma.
    Gutiérrez V; Prieto L; Torres V; Trenor R; Pérez C; Bertó JM; Marín J
    Ann Allergy Asthma Immunol; 1999 Jun; 82(6):559-65. PubMed ID: 10400484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum eosinophil cationic protein as a predictor of disease activity in acute and chronic asthma.
    Onadeko BO; Khadadah ME; Mustafa HT; Ezeamuzie CI; Marouf R; Khamis A; Sugathan TN
    East Afr Med J; 1999 Sep; 76(9):524-9. PubMed ID: 10685325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eosinophil cationic protein levels in induced sputum correlate with the severity of bronchial asthma.
    Fujimoto K; Kubo K; Matsuzawa Y; Sekiguchi M
    Chest; 1997 Nov; 112(5):1241-7. PubMed ID: 9367463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do sputum eosinophils and ECP relate to the severity of asthma?
    Ronchi MC; Piragino C; Rosi E; Stendardi L; Tanini A; Galli G; Duranti R; Scano G
    Eur Respir J; 1997 Aug; 10(8):1809-13. PubMed ID: 9272923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clarithromycin suppresses bronchial hyperresponsiveness associated with eosinophilic inflammation in patients with asthma.
    Amayasu H; Yoshida S; Ebana S; Yamamoto Y; Nishikawa T; Shoji T; Nakagawa H; Hasegawa H; Nakabayashi M; Ishizaki Y
    Ann Allergy Asthma Immunol; 2000 Jun; 84(6):594-8. PubMed ID: 10875487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eosinophil count and eosinophil cationic protein concentration of induced sputum in the diagnosis and assessment of airway inflammation in bronchial asthma.
    Park JW; Whang YW; Kim CW; Park YB; Hong CS
    Allergy Asthma Proc; 1998; 19(2):61-7. PubMed ID: 9578913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The influence oc glycocorticoid therapy on sputum ECP concentration in symptomatic patients with bronchial asthma].
    Hermanowicz-Salamon J; Grubek-Jaworska H; Wrońska J; Droszcz W; Chazan R
    Pneumonol Alergol Pol; 2002; 70(11-12):527-35. PubMed ID: 12884561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophilic inflammation in severe persistent asthma.
    Jatakanon A; Uasuf C; Maziak W; Lim S; Chung KF; Barnes PJ
    Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1532-9. PubMed ID: 10556116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inflammatory marker serum eosinophil cationic protein (ECP) compared with PEF as a tool to decide inhaled corticosteroid dose in asthmatic patients.
    Löwhagen O; Wever AM; Lusuardi M; Moscato G; De Backer WA; Gandola L; Donner CF; Ahlstedt S; Larsson L; Holgate ST
    Respir Med; 2002 Feb; 96(2):95-101. PubMed ID: 11862965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of nasal triamcinolone acetonide on seasonal variations of bronchial hyperresponsiveness and bronchial inflammation in nonasthmatic children with seasonal allergic rhinitis.
    Orhan F; Sekerel BE; Adalioglu G; Pinar M; Tuncer A
    Ann Allergy Asthma Immunol; 2004 Apr; 92(4):438-45. PubMed ID: 15104196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Airway inflammatory response to ozone in subjects with different asthma severity.
    Vagaggini B; Carnevali S; Macchioni P; Taccola M; Fornai E; Bacci E; Bartoli ML; Cianchetti S; Dente FL; Di Franco A; Giannini D; Paggiaro PL
    Eur Respir J; 1999 Feb; 13(2):274-80. PubMed ID: 10065667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of blood eosinophilia and the eosinophil cationic protein (ECP) in the serum of asthmatic children with varying degree of severity.
    Vilá-Indurain B; Muñoz-López F; Martín-Mateos M
    Allergol Immunopathol (Madr); 1999; 27(6):304-8. PubMed ID: 10611555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Impacts on asthma at persistent stage and immune function in the patients treated with acupuncture for warming yang and benefiting qi].
    Xie Y; Wan W; Zhao Y; Xie J; Wu Q
    Zhongguo Zhen Jiu; 2015 Nov; 35(11):1089-93. PubMed ID: 26939313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized pilot study of acupuncture as an adjunct therapy in adult asthmatic patients.
    Choi JY; Jung HJ; Kim JI; Lee MS; Kang KW; Roh YL; Choi SM; Jung SK
    J Asthma; 2010 Sep; 47(7):774-80. PubMed ID: 20701479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salmeterol decreases eosinophilic cationic protein and rescue medication in patients inhaling beclomethasone dipropionate: preliminary study in mild and moderate asthma in Trinidad, West Indies.
    Pinto Pereira LM; Clement Y; Rouse J; Matthew J; Asgarali Z; Ramoutar D; Teelucksingh S
    Int J Clin Pharmacol Res; 2003; 23(2-3):69-74. PubMed ID: 15025036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once-daily theophylline reduces serum eosinophil cationic protein and eosinophil levels in induced sputum of asthmatics.
    Aizawa H; Iwanaga T; Inoue H; Takata S; Matsumoto K; Takahashi N; Yoshida M; Hara N
    Int Arch Allergy Immunol; 2000 Feb; 121(2):123-8. PubMed ID: 10705222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Airway function correlates with circulating eosinophil, but not mast cell, markers of inflammation in childhood asthma.
    Rao R; Frederick JM; Enander I; Gregson RK; Warner JA; Warner JO
    Clin Exp Allergy; 1996 Jul; 26(7):789-93. PubMed ID: 8842552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of a transdermal therapeutic system of the beta2-agonist tulobuterol in patients with mild or moderate persistent bronchial asthma.
    Horiguchi T; Kondo R; Miyazaki J; Fukumokto K; Torigoe H
    Arzneimittelforschung; 2004; 54(5):280-5. PubMed ID: 15212190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.